Please assess the completion status of the following clinical trial:

Trial Title: The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent~* Males aged 45-85 years~* \>60% of the voiding volume is above 100 ml per voiding verified by a urinary diary~* Able to read write and understand given instructions~Exclusion Criteria:~* Patients practicing CIC~* Ongoing symptomatic UTI~* Known Neurological Disease that is affecting the bladder function~* Known past or present alcohol or drug abuse~* Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site)~* Previous enrolment or randomisation of treatment in the present study.~* Suspected poor compliance based on less than 80 % compliance to voiding diary~* Severe non-compliance to protocol as judged by the investigator and/or Astra Tech~* On alpha-blocker or 5-alpha reductase inhibitor treatment, treatment started less than 2 months prior to enrolment~* Clinic flow below 100 ml

- Gender: MALE
- Minimum Age: 45 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Disposable device first, then Digital device (Type: EXPERIMENTAL): None
- Digital device first, then Disposable device (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).